
Grants Awarded
Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.
New awards will be posted as they are issued.
Year |
Award Type![]() |
Project # | RFA # | PI/Project Leader | Institution | Title | Status |
---|---|---|---|---|---|---|---|
2019 | R21 | CA240199 | RFA-CA-18-002 | O'NEILL, RACHEL | UNIVERSITY OF CONNECTICUT STORRS | Development and Utilization of Splice-specific Antibodies | Active |
2000 | R21 | CA088335 | PAR-99-100 | SUTHERLAND, JOHN CLARK | BROOKHAVEN SCIENCE ASSOC-BROOKHAVEN LAB | DNA DAMAGE QUANTITATION BY SINGLE MOLECULE LASER SIZING | Complete |
2002 | R21 | EB000807 | PAR-99-100 | SWANSON, BASIL I. | UNIVERSITY OF CALIF-LOS ALAMOS NAT LAB | OPTICAL BIOSENSOR FOR THE EARLY DETECTION OF CANCER | Complete |
2005 | R21 | CA112147 | RFA-CA-05-003 | HYSLOP, TERRY | THOMAS JEFFERSON UNIVERSITY | NONLINEAR MODELS OF MRNA EXPRESSION IN CANCER BY RT-PCR | Complete |
2008 | R21 | CA132039 | RFA-CA-07-035 | NELSON, EDWARD L | UNIVERSITY OF CALIFORNIA-IRVINE | APPLICATION OF A NOVEL NANOTECHNOLOGY FOR MOLECULAR PROFILING OF TUMOR CELLULAR E | Complete |
2011 | R21 | CA155479 | RFA-CA-10-005 | MCDONALD, JOHN F | GEORGIA INSTITUTE OF TECHNOLOGY | USE OF NANOGELS TO TARGET DELIVERY OF SIRNA TO CANCER CELLS IN MICE | Complete |
2015 | R21 | CA196426 | RFA-CA-14-003 | VO-DINH, TUAN | DUKE UNIVERSITY | NANOPLASMONICS-BASED MOLECULAR ANALYSIS TOOL FOR MOLECULAR BIOMARKERS OF CANCER | Complete |
2010 | R21 | CA137703 | RFA-CA-09-008 | LIU, GUODONG | NORTH DAKOTA STATE UNIVERSITY | DEVELOPMENT OF A HAND-HELD CANCER BIOMARKER MONITOR | Complete |
2007 | R21 | CA126700 | RFA-CA-07-001 | DING, ZHIYONG | UT MD ANDERSON CANCER CTR | EFFECTIVE MAMMALIAN TWO HYBRID SCREENING APPROACH | Complete |
2006 | R21 | CA120732 | RFA-CA-06-003 | MEYER, TOBIAS | STANFORD UNIVERSITY | DISSECTION OF THE MODULAR STRUCTURE OF CANCER SIGNALING SYSTEMS | Complete |
2009 | R21 | CA138295 | RFA-CA-08-006 | LESSNICK, STEPHEN L. | UNIVERSITY OF UTAH | ANTIBODY-BASED DETECTION OF TRANSLOCATIONS IN PEDIATRIC CANCER | Complete |
2012 | R21 | CA173205 | RFA-CA-12-002 | TAO, NONGJIAN | ARIZONA STATE UNIVERSITY-TEMPE CAMPUS | CHARGE SENSITIVE OPTICAL DETECTION FOR HIGH THROUGHPUT STUDY OF SMALL MOLECULES | Complete |
2016 | R21 | CA204706 | RFA-CA-15-002 | BURGETT, ANTHONY WG | UNIVERSITY OF OKLAHOMA NORMAN | MASS SPECTROMETRY DETECTION OF DRUGS IN SINGLE BLADDER CANCER CELLS FROM PATIENTS | Complete |
2019 | R21 | CA240580 | RFA-CA-18-002 | MONTAGNA, CRISTINA | ALBERT EINSTEIN COLLEGE OF MEDICINE | Development of a high-resolution mapping platform for HPV DNA integration in premalignant lesions | Active |
2000 | R21 | CA086132 | PAR-99-100 | MAJUMDAR, ARUNAVA | UNIVERSITY OF CALIFORNIA BERKELEY | OPTOMECHANICAL CHIPS FOR MOLECULAR PROFILING OF CANCER | Complete |
2002 | R21 | CA094393 | PAR-99-102 | CHODOSH, LEWIS A | UNIVERSITY OF PENNSYLVANIA | TEMPORAL ANALYSIS OF MAMMARY CARCINOGENESIS | Complete |
2005 | R21 | CA116365 | RFA-CA-05-003 | GREEN, ROLAND D | NIMBLEGEN SYSTEMS, INC. | MAPPING REGULATORY PATHWAYS IN CANCERS | Complete |
2008 | R21 | CA126635 | RFA-CA-07-035 | KEELY, PATRICIA J | UNIVERSITY OF WISCONSIN-MADISON | USING NEW OPTICAL TECHNIQUES TO STUDY CELL SIGNALING IN 3D MATRICES | Complete |
2011 | R21 | CA157417 | RFA-CA-10-005 | ZEICHNER, STEVEN L | CHILDREN'S RESEARCH INSTITUTE | DEVELOPMENT OF AN IN VIVO SCREENING TECHNOLOGY FOR CANCER VACCINE IMMUNOGENS | Complete |
2015 | R21 | CA191133 | RFA-CA-14-005 | MITRAGOTRI, SAMIR S | UNIVERSITY OF CALIFORNIA SANTA BARBARA | ASSESSING THE RISK OF UV-INDUCED SKIN CANCER VIA NON-INVASIVE EPIDERMAL SAMPLING | Complete |
2022 | R21 | CA261775 | CA21-003 | LIN, QIAO | COLUMBIA UNIV NEW YORK MORNINGSIDE | A Practical Approach to Tumor-Specific Aptamers for B-Cell Hematologic Malignancies | Active |